Abstract
In the original version of this article (1), Ovcar3 cell line data in Fig. 2D was a duplicate of the Ovcar10 cell line data. This duplication was inadvertent and does not affect the main conclusions of the study. The graph for Ovcar3 has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 797 |
| Number of pages | 1 |
| Journal | Molecular Cancer Research |
| Volume | 18 |
| Issue number | 5 |
| DOIs |
|
| State | Published - May 1 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Erratum: Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer (Molecular Cancer Research (2019) 17 (1710-1720) DOI: 10.1158/1541-7786)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver